Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma

Oncotarget. 2024 Oct 11:15:725. doi: 10.18632/oncotarget.28663.
No abstract available

Publication types

  • Retraction of Publication